Kevin Kim

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Research Funding
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    Research Funding
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ImmunoCore
    Topic:
    Research Funding
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Iovance
    Topic:
    Research Funding
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Moderna
    Topic:
    Research Funding
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Ideaya
    Topic:
    Research Funding
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Replimmune
    Topic:
    Research Funding
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Regeneron
    Topic:
    Research Funding
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Summit
    Topic:
    Research Funding
    Date added:
    01/09/2025
    Date updated:
    01/09/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Speakers Bureau
    Date added:
    01/09/2025
    Date updated:
    01/09/2025

Pages

Return to Northern California Hematology Oncology Conference: A Tumor Board Case-Based Approach to the Latest Breakthroughs